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Chemokines are a large family of structurally related chemoattractive cytokines, which have
four conserved cysteines forming two disulfide bonds, and act through seven-transmembrane-
spanning receptors coupled to heterotrimeric GTP-binding proteins (G-protein-coupled receptors).
Chemokines were thought to be signaling molecules that attract leukocytes to sites of inflammation;
however, CXC chemokine ligand (CXCL)12 [also known as stromal cell-derived factor (SDF)-1α
and pre-B-cell-growth-stimulating factor (PBSF)] is the first member that was shown to be critical
for developmental processes, including hematopoiesis (1), cardiogenesis (1–3), vascular formation
(2), and neurogenesis (3), as well as the maintenance of tissue stem cells (4).
Identification of CXCL12
Our interest is how bone marrow microenvironments regulate hematopoiesis, including B lym-
phopoiesis. To address this, we tried to identify a cytokine, which was important for B cell
development in themarrow. In 1988, Namen et al. identified interleukin 7 (IL-7) produced by a bone
marrow-derived stromal cell line as a cytokine, which enhanced the proliferation of B cell precursors.
However, several studies suggested that IL-7 was not sufficient to support B lymphopoiesis. Hayashi
et al. speculated that at first stage in B cell development, progenitors depended on unidentified
molecules produced by the stromal cell line called PA6 alone for proliferation and differentiation
into the second stage, where progenitors depended on both PA6-derived factors and IL-7 for
proliferation (5).
It was unclear whether PA6-derived factors were soluble factors or not in Hayashi’s model (5).
To address this issue, we cultured bone marrow hematopoietic cells in the absence or presence of
PA6 cells separated by a membrane filter, allowing the passage of proteins but not cells. We showed
that while very few viable B cell precursors were present 7 days after the culture of bone marrow
hematopoietic cells in the presence of IL-7 and absence of PA6 cells, the proliferation of B cell
precursors were enhanced in the presence of PA6 and IL-7. These findings suggested the existence
of soluble factors produced by PA6 cells that stimulated the proliferation of B cell precursors in the
presence of IL-7 (6).
We tried to develop more simple culture system suitable for molecular cloning and found that
a stromal cell-dependent B cell precursor clone, DW34, which was established from Whitlock-
Witte-type culture by limiting dilution on a stromal cell line, could proliferate in the presence of
a conditioned medium from PA6 cells (6). An expression cDNA library was prepared from PA6
cells using the vector pME18S, and then more than 104 pools were screened for the activity to
stimulate the growth of DW34 cells after enforced expression in COS-7 cells, and positive pool was
subdivided until a single positive clone was identified.We revealed that a conditionedmedium from
the positive clone-transfected COS-7 cells had DW34 growth stimulating activity and termed this
molecule PBSF (6). The nucleotide sequence and deduced amino acid sequence of the clone were
determined and its product was identical to a chemokine called SDF-1α (6, 7). We felt these results
somewhat disappointing because chemokines were thought to be rather inflammatory mediators at
that time. In 1993, Tashiro et al. developed a method for molecular cloning of cDNAs that contain
Frontiers in Immunology | www.frontiersin.org June 2015 | Volume 6 | Article 3011
Nagasawa The chemokine critical for development
signal sequences, such as those encoding secreted proteins and
receptors without the use of specific functional assays, and iden-
tified SDF-1α; however, its function was unclear (7). Thus, we
revealed that SDF-1α/PBSF (now formally named CXCL12) stim-
ulated the proliferation of B cell precursors (6).
Identification of a Receptor for CXCL12
All known chemokine receptors are G-protein-coupled recep-
tors (GPCR) and amino acid sequence is conserved among
these molecules. Based on this, we synthesized four degen-
erate oligonucleotides corresponding to conserved amino acid
sequences in transmembrane regions of the chemokine recep-
tors, including murine CXCR2, CCR2, and human HUMSTR,
and used them as primers in PCR experiments to identify
chemokine receptors abundantly expressed by murine CXCL12
responsive DW34 cells (8). The deduced amino acid sequence
of a cDNA yielded by this approach shared 90% amino acid
identity with previously identified human HUMSTR/HM89/
LESTR/fusin, a HIV-1 entry co-receptor and designated murine
HUMSTR/HM89/LESTR/fusin (now formally named CXCR4)
(8). CXCL12 induced an increase in intracellular free Ca2+
in DW34 cells and CXCR4-transfected Chinese hamster ovary
(CHO) cells, suggesting that CXCR4 is a receptor for CXCL12 (8).
On the other hand, Bleul et al. andOberlin et al. demonstrated that
human HUMSTR/HM89/LESTR/fusin is a receptor for human
CXCL12 (9, 10). The majority of chemokine receptors recognize
more than one chemokine, and many chemokines bind to more
than one chemokine receptor. However, we and others revealed
that mice lacking CXCR4 showed hematopoietic and cardiovas-
cular phenotypes strikingly similar to those of CXCL12 deficient
mice, as described below, indicating that CXCR4 is the primary
physiologic receptor for CXCL12 in mammals (1–3).
Essential Physiological Roles of
CXCL12–CXCR4 Signaling
To determine the role of CXCL12 in hematopoiesis, we generated
and analyzed CXCL12 and CXCR4 deficient mice, which died
perinatally. Consistent with the activities of CXCL12 in promot-
ing the proliferation of B cell precursors (6), CXCL12-CXCR4
signaling was essential for the development of B cells from the
earliest precursors in fetal liver and bone marrow (1, 11). Surpris-
ingly, CXCL12-CXCR4 signaling was also essential for homing
of hematopoietic stem cells (HSCs) and neutrophils to fetal bone
marrow during ontogeny (1–3, 12). Subsequently, we generated
CXCR4 conditionally deficient mice and revealed that CXCL12-
CXCR4 signaling was essential for the maintenance of HSCs,
the production of immune cells, including B cells, plasmacytoid
dendritic cells (pDCs), which expressed high levels of type I inter-
feron (IFN), and were thought to play important roles in antiviral
immunity, and NK cells and homing of end-stage B cells, plasma
cells into bone marrow (4, 11, 13). In addition to hematopoiesis,
we found that CXCL12-CXCR4 signalingwas essential for homing
of primordial germ cells (PGCs) to gonads, a cardiac ventricu-
lar septal formation and vascularization of the gastrointestinal
tract during ontogeny (1–3). In the meantime, Littmann’s group
described that CXCR4 was essential for migration of granule cells
in appropriate positions in the cerebellum during neurogenesis
(3), and besides these additional physiological roles of CXCL12-
CXCR4 signaling, other groups revealed its relevant pathological
roles. In 1996, Feng et al. found that CXCR4 acted as an essen-
tial co-receptor for T cell-tropic strains of human immunodefi-
ciency virus type-1 (HIV-1), and Bleul et al. and Oberlin et al.
demonstrated that CXCL12 hadHIV-suppressive activities (9, 10).
Furthermore, CXCL12-CXCR4 signaling has been reported to
be involved in migration of cancer cells, including presumptive
cancer stem cells, to sites ofmetastasis and increased their survival
and/or growth in various cancers, such as breast and lung cancers,
as well as leukemia and lymphoma.
CXCL12-Expressing Cells in Bone Marrow
As the CXCL12-CXCR4 signaling plays a key role in
hematopoiesis, we were prompted to visualize cells, which
expressed CXCL12 in bone marrow. For this, we generated mice
with the green fluorescent protein (GFP) reporter gene knocked
into the CXCL12 locus and found that CXCL12 as well as stem
cell factor (SCF), which was essential for HSC proliferation, was
preferentially expressed in a population of stromal cells with
long processes, termed CXCL12-abundant reticular (CAR) cells
(11–13). CAR cells are adipo-osteogenic progenitors, which
express adipogenic and osteogenic genes, including peroxisome
proliferator-activated receptor γ (PPARγ) and Osterix (Osx),
and largely overlap with SCF-expressing cells predominantly
expressing leptin receptor (Lepr) (13–15). Histological analysis
showed that most HSCs and very early B cell progenitors were
in contact with CAR cells (4, 11), and the experiments using
diphtheria toxin-based system that allows the inducible, short-
term ablation of CAR cells in vivo revealed that CAR cells were
essential for maintenance of hematopoietic stem and progenitor
cells (HSPCs) in bonemarrow (Figure 1) (14). Recently, we found
that the transcription factor Foxc1 was expressed preferentially
in CAR cells and was essential for CAR cell development and
maintenance of bone marrow niches for HSPCs up-regulating
FIGURE 1 | CXCL12-abundant reticular (CAR) cells. In adult bone
marrow, the transcription factor Foxc1 induces development of CAR cells and
maintains bone marrow niches for HSPCs, up-regulating the expression of
CXCL12, which is essential for the maintenance of HSCs, common lymphoid
progenitors (CLPs), B cells, pDCs, and NK cells, in CAR cells.
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SCF and CXCL12, which plays major roles in HSC maintenance
and immune cell production (Figure 1) (15).
Taken together, CXCL12 and CXCR4 have been identified as
key spatiotemporal regulators of migratory stem and progenitor
cell behavior, and our studies provide considerable new insights
into the biology and pathology of tissue stem cells as well as
hematopoiesis, vasculogenesis, and neurogenesis, and in some
cases, for clinical application in various diseases.
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